Previous 10 | Next 10 |
Gainers: Diffusion Pharmaceuticals (NASDAQ: DFFN ) +49% . ARCA biopharma (NASDAQ: ABIO ) +47% . Digimarc Corporation (NASDAQ: DMRC ) +46% . Hudson Technologies (NASDAQ: HDSN ) +23% . InspireMD (NYSEMKT: NSPR ) +17% . Materion Corporation (NYSE: MTRN ) +16% . Precipio (NASD...
NEW HAVEN, Conn., May 01, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), will host a conference call on Monday, May 6 th , 2019 at 5:00pm Eastern Time to review recent company and business events, and provide a corporate update. During the call...
PRPO stock jumped more than 30% Wednesday. The increase comes two days after Precipio Inc (NASDAQ:PRPO) said it signed a services contract with multiple hospitals in Cairo, Egypt. Following the news, PRPO stock jumped 9% Monday, only to continue its run of good luck today. Here’s...
Gainers: ARCA biopharma (NASDAQ: ABIO ) +37% . MFC Bancorp (NYSE: MFCB ) +32% . Enphase Energy (NASDAQ: ENPH ) +29% . Precipio (NASDAQ: PRPO ) +25% . Nu Skin Enterprises (NYSE: NUS ) +25% . Nanometrics Incorporated (NASDAQ: NANO ) +22% . Qumu Corporation (NASDAQ: QUMU ) +22% ....
MICT (NASDAQ: MICT ) -29% . More news on: MICT, Inc., Micro Focus International plc, Precipio, Inc., Stocks on the move, , Read more ...
Precipio (NASDAQ: PRPO ) +38% on first major international services contract. More news on: Precipio, Inc., Innovate Biopharmaceuticals, Inc., Changyou.com Limited, Stocks on the move, Read more ...
Nano cap Precipio (NASDAQ: PRPO ) is up 28% premarket on average volume in reaction to its services contract with several hospitals in Cairo, Egypt. Initially, the agreement will involve sending patient biopsies for to the company for primary diagnoses and second opinions. Mo...
NEW HAVEN, Conn., April 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has signed a services contract with a health care management group serving several major hospitals based in Cairo, Egypt. Precipio is engag...
NEW HAVEN, Conn., April 26, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has implemented a 1-for-15 reverse stock split of outstanding shares of the company's common stock in order to regain compliance with the N...
NEW HAVEN, Conn., April 24, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) announces the launch of Precipio’s global pathology services. The services are intended to create a renewed and enhanced revenue stream by monetizing the expertise...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...